Management Team

Combining oncology drug development and biomarker technology experience to improve cancer care

Charles Monahan, RPh

Senior Vice President, Regulatory Affairs

Mr. Monahan has served as Sr. Vice President of Regulatory Affairs since 2021. Mr. Monahan is a registered pharmacist with extensive experience in clinical pharmacy, healthcare management, and pharmaceutical development. He has over 20 years of regulatory experience developing drugs and biologics for oncology, infectious diseases, and ocular indications.

Most recently, Mr. Monahan served as the Global Head of Regulatory Affairs for Erytech PharmaSA where he led the regulatory strategy and execution of the company’s lead asset across multiple oncology indications in both the United States and Europe. Prior to Erytech, Mr. Monahan held senior regulatory positions at several pharmaceutical companies including Millennium Pharmaceuticals, Molecular Insight Pharmaceuticals, AVEO Pharmaceuticals, and Transgene SA covering all stages of development, preclinical through post-commercialization.

Mr. Monahan earned his BS in Pharmacy from the University of Rhode Island and a MS in Regulatory Affairs and Health Policy from the Massachusetts College of Pharmacy and Health Sciences.